A set of new N2- (thien-3-yl)amidrazones (6a-h) incorporating N-piperazines and related congeners has been synthesized by reacting the hydrazonoyl chloride 4 (derived from 3-aminothiophene-2-carboxylate) with the appropriate sec-cyclic amine. The antitumor activity of these compounds was evaluated on breast cancer (MCF-7) and leukemic (K562) cell lines by a cell viability assay utilizing the tetrazolium dye (MTT). The amidrazone 6d encompassing the N-piperazine moiety, was the most active against MCF-7 and K562 with IC 50 of 7.28 and 9.91 µ M, respectively.
Introduction
Recently, we have reported on the synthesis and antitumor activity of some N-aryl(piperazin-1-yl) amidrazones exemplified by 1a and 1b ( Fig. 1 ) [1] . Both compounds bear significant antitumor activity against a number of human cell lines, especially leukemia, breast cancer, non-small cell lung cancer and CNS cancers. Moreover, and equally pertinent to the present investigation, N-(aryl)amidrazones (possessing the -C 6 H 4 -NH-C(COMe)=N-NH-C 6 H 4 fragment) have recently been found to be a potent corticotrophin-releasing factor (CRF) receptor antagonist [2] . Several publications have also dealt with the synthesis and evaluation of thrombin inhibitors that incorporate an amidrazone functionality as a structural motif [3 -5] .
In light of the above information and based on the concept of bioisosterism interchange in drug design [6 -10] , we thought it would be worthwhile to replace the benzene ring in 1a, b by the classical bioiososteric thiophene ring. Accordingly, the present work aims at the synthesis of N2-(thien-3-yl)amidrazones (6a-h, see Scheme 2) incorporating piperazines and their congeners for evaluation of their antitumor activity.
Results and Discussion

Synthesis
The synthetic route towards a selected set of N2-(thien-3-yl) amidrazone derivatives (6a-h, see Scheme 2) commenced with the preparation of methyl 3-[2-(1-chloro-2-oxopropylidene) hydrazinyl] thiophene-2-carboxylate (4, Scheme 1). Thus, diazotization of the amino group of methyl 3-amino-2-thiophenecarboxylate (2), followed by coupling of the resulting thiophene-3-diazonium salt (2A) with 3-chloropentane-2, 4-dione (in basic medium) gave initially the α-chloroazo compound (3A) (Scheme 1); the latter intermediate was then transformed (under the basic reaction conditions) into the respective more stable α-chlorohydrazone structure 4 via loss of the acetyl group (Japp-Klingemann reaction) [11 -13] .
Piperazines and the related sec-cyclic amines 5a-h, acting as nitrogen nucleophiles, are expected to add readily onto N2-(thien-3-yl) nitrile amine (the reactive 1,3-dipolar species generated in situ from its corresponding hydrazonoyl chloride precursor 4 in the presence of triethylamine) to deliver the respective amidrazone adducts 6a-h (Scheme 2). This mode of nucleophilic addition reaction of various nucleophiles onto 1,3-dipoles is well-documented in the literature [14 -20] .
The newly synthesized compounds 4 and 6a-h were characterized by elemental analyses, MS and NMR spectral data. These data, detailed in the Experimental Section, are in conformity with the assigned structures. The mass spectra display the correct molecular ion peaks for which the measured high-resolution (HRMS) data are in good agreement with the calculated values. DEPT and 2D (HMQS, HMBC) experiments showed correlations that helped in the 1 H and 13 C signal assignments to the different carbons and their attached, and/or neighboring hydrogens. In compound 6h, the skeletal carbons of the fluorinated benzene ring are recognizable by their doublet signals (with varying J values) originating from scalar (through bond) coupling with the neighboring fluorine atom at the C-4 locus. In HMBC experiments, distinct long-range "three-bond" correlations are observed between 5-H and each of C-2 and C-3, between 4-H and C-2, as well as between the amidrazone N-H and each of C-2 and the amidrazone carbon (HN-N=C).
Antitumor activity
The antitumor activity of the synthesized compounds was screened by conducting cell viability assay using the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Cultures of the breast cancer cell line MCF-7 and the leukemic cell line K562 were treated first at two concentrations of 12.5 and 50 µ M, and the results are shown in Table 1 . In the MCF-7 screening test, only compounds 6h and 6d showed a potential anti-MCF-7 activity at 12.5 µ M concentration. At 50 µ M concentration, 6f and 6h were able to reduce the proliferation to less than 50 %, indicating that these two compounds may have some potential anti-MCF-7 activity albeit to a lesser extent than 6d. In the case of K562 cells, only compound 6d illustrated a potential anti-K562 activity and again was able to reduce the viability after 72 hours to less than 50 % at both, 12.5 µ M Table 2 . From the structure-activity relationships point of view, the nature of the substituent at position X (see Scheme 2) seems to play a critical role in determining the anti-cancer activity. Clearly, different substitution at position X results in remarkable variations in the determined anti-tumor activity. For example, compounds 6e, 6g, 6c, and 6b that have N-Me, N-CHO, S or O substituents at position X showed very little, if any, anti-MCF-7 and anti-K562 activity, while compounds 6d, 6f, and 6h with N-H, N-CO 2 Et, and N-C 6 H 4 F(p) groups showed a promising activity; in particular, compound 6d has a very encouraging IC 50 against both, MCF-7 and K562.
Experimental Section
The following chemicals were purchased from Acros and were used as received: methyl 3-amino-2-thiophenecarboxylate, 3-chloro-2,4-pentanedione, piperidine, morpholine, thiomorpholine, piperazine, 1-methylpiperazine, 1-formylpiperazine, 1-(ethoxycarbonyl)piperazine, and 1-(4-fluorophenyl)piperazine. Melting points were determined on a Gallenkamp electrothermal apparatus in open capillary tubes. Elemental analyses were performed on a Euro Vector analyzer, model EA 3000. 1 H and 13 C NMR spectra were recorded on a 500 MHz spectrometer (Bruker Advance-III) with TMS as the internal standard. Chemical shifts are expressed in δ units; J values for 1 H-1 H, 1 H-19 F and 13 C- 19 F coupling constants are given in Hertz. High resolution mass spectra (HRMS) were acquired (in positive mode) using the electrospray ion trap (ESI) technique by collision-induced dissociation on a Bruker APEX-4 (7 Tesla) instrument. The samples were dissolved in acetonitrile, diluted in spray solution (methanol-water 1 : 1 v/v + 0.1 % formic acid) and infused using a syringe pump with a flow rate of 2 µL min −1 . External calibration was conducted using arginine clusters in a mass range m/z = 175 -871.
Cell lines and cell culture
The K562 leukemia cell line was obtained from Dr. Mona Hassona (Department of Biological Sciences, The University of Jordan) and was cultured in RPMI, while the MCF-7 breast cancer cells were obtained from American Type Culture Collections (ATCC) and were cultured in RPMI. All media were supplemented with 10 % heat-inactivated fetal bovine serum (FBS) (Gibco Invitrogen), 1 % of 2 mM L-glutamine (Lonza), 50 IU per mL penicillin (Lonza), and 50 µg mL −1 streptomycin (Lonza), and cells were maintained at 37 • C, 5 % CO 2 in a humidified incubator.
Cell proliferation assay
MCF-7 and K562 cells were seeded at a density of 1 × 10 4 and 4 × 10 4 cells per well in 96-well plates in appropriate medium. For anti-MCF-7 and anti-K562 screening, the cells were treated with 12.5 and 50 µ M concentrations of the tested compounds. For the IC 50 determination, the cells were treated with increasing concentrations of the tested compound (1.56 -100 µ M). In all assays, the drugs were dissolved in DMSO immediately before the addition to cell cultures, and equal amounts of the solvent were added to control cells. Cell viability was assessed, after 3 days of treatment, with the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), obtained from Sigma (Dorset, UK). IC 50 concentrations were obtained from the dose-response curves using GRAPHPADPRISM Software 5 (San Diego, California, USA; www.graphpad.com).
Methyl 3-[2-(1-chloro-2-oxopropylidene)hydrazinyl]-thiophene-2-carboxylate (4)
The title compound was prepared by the following two steps: step 
Thiophene-3-amidrazone derivatives 6a-h; general procedure
To a cold (0 -5 • C) and stirred suspension of 4 (1.3 g, 5 mmol) in ethanol (30 mL) was added a solution of the appropriate cyclic sec-amine 5a-h (7 mmol) and triethylamine (5 mL) in ethanol (10 mL). Stirring was continued at 0 -5 • C for 2 -4 h, and at ambient temperature for additional 2 h; the reaction mixture was then poured onto cold water (200 mL). The resulting crude solid product was collected by suction filtration, washed with cold water, dried and recrystallized from dichloromethane-cyclohexane.
Methyl 3-{2-[2-oxo-1-(piperidin-1-yl)propylidene]-hydrazinyl}thiophene-2-carboxylate (6a)
Yield: 76 %, m. p. 102 -104 • C. 
